Cited by 1,043Neurological diseases and metabolismParkinson's Disease Mechanisms and TreatmentsTrace Elements in Health

The DOI matches its Crossref record.

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E, LEES, A. J., JENNER, P., MARSDEN, C. D.·1991·Brain

DOI 10.1093/brain/114.4.1953

Open this paper in CoChat — free account

Abstract

Levels of iron, copper, zinc and manganese were measured by inductively coupled plasma spectroscopy in frozen postmortem brain tissue from patients with Parkinson's disease (PD), progressive supranuclear palsy (PSP), multiple system atrophy with strionigral degeneration (MSA), and Huntington's disease (HD) compared with control subjects. Total iron levels were found to be elevated in the areas of basal ganglia showing pathological change in these disorders. In particular, total iron content was increased in substantia nigra in PD, PSP and MSA, but not in HD. Total iron levels in the striatum (putamen and/or caudate nucleus) were increased in PSP, MSA and HD but not in PD. Total iron levels were decreased in the globus pallidus in PD. There were no consistent alterations of manganese levels in basal ganglia structures in any of the diseases studied. Copper levels were decreased in the substantia nigra in PD, and in the cerebellum in PSP, and were elevated in the putamen and possibly substantia nigra in HD. Zinc levels were only increased in PD, in substantia nigra and in caudate nucleus and lateral putamen. Levels of the iron binding protein ferritin were measured in the same patient groups using a radio-immunoassay technique. Increased iron levels in basal ganglia were generally associated with normal or elevated levels of ferritin immunoreactivity, for example, the substantia nigra in PSP and possibly MSA, and in putamen in MSA. The exception was PD where there was a generalized reduction in brain ferritin immunoreactivity, even in the substantia nigra. An increase in total iron content appears to be a response to neurodegeneration in affected basal ganglia regions in a number of movement disorders. However, only in PD was there an increased total iron level, decreased ferritin content, decreased copper content, and an increased zinc concentration in substantia nigra. These findings suggest an alteration of iron handling in the substantia nigra in PD. Depending on the form in which the excess iron load exists in nigra in PD, it may contribute to the neurodegenerative process.

Integrity signals

Registry

Crossref · 10.1093/brain/114.4.1953

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 301–400 of 1,000

The Potential Role of Iron Chelators in the Treatment of Parkinson's Disease and Related Neurological Disorders
Gassen, M., & Youdim, M. B. H. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00390.x · Cited by 77
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
Hare, D. J., Adlard, P. A., Doble, P. A., & Finkelstein, D. I. (2013) · Metallomics · doi:10.1039/c2mt20164j · Cited by 78
6-Hydroxydopamine: a far from simple neurotoxin
Varešlija, D., Tipton, K. F., Davey, G. P., & McDonald, A. G. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-019-02133-6 · Cited by 80
Transition metal abnormalities in progressive dementias
Akatsu, H., Hori, A., Yamamoto, T., Yoshida, M., Mimuro, M., Hashizume, Y., Tooyama, I., & Yezdimer, E. M. (2011) · BioMetals · doi:10.1007/s10534-011-9504-8 · Cited by 78
Dopamine and Iron Induce Apoptosis in PC12 Cells
Velez‐Pardo, C., Jiménez-Del-Río, M., Verschueren, H., Ebinger, G., & Vauquelin, G. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00287.x · Cited by 77
Quantification of trace elements in normal human brain by inductively coupled plasma atomic emission spectrometry
Rajan, M. T., Rao, K. S. J., Mamatha, B. M., Rao, R. V., Shanmugavelu, P., Menon, R. B., & Pavithran, M. V. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00300-0 · Cited by 77
Targeting the Progression of Parkinsons Disease
George, J., Mok, S., Moses, D., Wilkins, S., Bush, A., Cherny, R., & Finkelstein, D. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602814 · Cited by 77
Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and Iron
Hegde, M. L., Hegde, P. M., Holthauzen, L. M. F., Hazra, T. K., Rao, K. S. J., & MITRA, S. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.126664 · Cited by 76
Memory deficits in adult rats following postnatal iron administration
Schröder, N. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00236-4 · Cited by 76
Quantitative susceptibility mapping in atypical Parkinsonisms
Mazzucchi, S., Frosini, D., Costagli, M., Prete, E. D., Donatelli, G., Cecchi, P. C., Migaleddu, G., Bonuccelli, U., Ceravolo, R., & Cosottini, M. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101999 · Cited by 78
Comparison of t2 relaxation in blood, brain, and ferritin
Brooks, R. A., Vymazal, J., Baumgarner, C. D., Tran, V., & Bulte, J. W. M. (1995) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880050414 · Cited by 76
Disentangling in vivo the effects of iron content and atrophy on the ageing human brain
Lorio, S., Lutti, A., Kherif, F., Ruef, A., Dukart, J., Chowdhury, R., Frackowiak, R. S. J., Ashburner, J., Helms, G., Weiskopf, N., et al. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.09.044 · Cited by 74
A multicontrast approach for comprehensive imaging of substantia nigra
Langley, J. A., Huddleston, D. E., Chen, X., Sedlacik, J., Zachariah, N., & Hu, X. P. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.02.045 · Cited by 76
Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease
Hartley, A., Cooper, J. M., & Schapira, A. H. V. (1993) · Brain Research · doi:10.1016/0006-8993(93)90341-j · Cited by 75
Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
Kawahata, I., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113779 · Cited by 71
Interaction Between α-Synuclein and Metal Ions, Still Looking for a Role in the Pathogenesis of Parkinson’s Disease
Bisaglia, M., Tessari, I., Mammi, S., & Bubacco, L. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8082-1 · Cited by 74
Synaptic Zinc: An Emerging Player in Parkinson’s Disease
Sikora, J., & Ouagazzal, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094724 · Cited by 71
The future of susceptibility contrast for assessment of anatomy and function
Reichenbach, J. R. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.004 · Cited by 73
Parkinson’s Disease: The Mitochondria-Iron Link
Muñoz, Y., Carrasco, C. M., Campos, J., Aguirre, P., & Núñez, M. T. (2016) · Parkinson s Disease · doi:10.1155/2016/7049108 · Cited by 76
The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint
Kaindlstorfer, C., Jellinger, K. A., Eschlböck, S., Stefanova, N., Weiß, G., & Wenning, G. K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170601 · Cited by 72
Brain proteins that mind metals: a neurodegenerative perspective
Brown, D. R. (2009) · Dalton Transactions · doi:10.1039/b822135a · Cited by 72
Manganese oxidation state mediates toxicity in PC12 cells
Reaney, S. H., & Smith, D. R. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.013 · Cited by 72
Copper Efflux from Murine Microvascular Cells Requires Expression of the Menkes Disease Cu-ATPase
Qian, Y., Tiffany‐Castiglioni, E., Welsh, J., & Harris, E. D. (1998) · Journal of Nutrition · doi:10.1093/jn/128.8.1276 · Cited by 72
Measuring the iron content of dopaminergic neurons in substantia nigra with MRI relaxometry
Brammerloh, M., Morawski, M., Friedrich, I., Reinert, T., Lange, C., Pelicon, P., Vavpetič, P., Jankuhn, S., Jäger, C., Alkemade, A., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118255 · Cited by 76
Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs
Tosato, M., & Marco, V. D. (2019) · Biomolecules · doi:10.3390/biom9070269 · Cited by 71
Disease‐toxicant screen reveals a neuroprotective interaction between Huntington’s disease and manganese exposure
Williams, B. B., Li, D. D., Węgrzynowicz, M., Vadodaria, B. K., Anderson, J. G., Kwakye, G. F., Aschner, M., Erikson, K. M., & Bowman, A. B. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06445.x · Cited by 70
Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions
Kaji, S., Maki, T., Ishimoto, T., Yamakado, H., & Takahashi, R. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-0185-5 · Cited by 71
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Riederer, P. F., Monoranu, C., Strobel, S., Iordache, T., & Sian‐Hülsmann, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02414-z · Cited by 69
Manganese uptake into rat brain during development and aging
Takeda, A., Ishiwatari, S., & Okada, S. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990401)56:1 · Cited by 69
Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson’s disease
Friedrich, I., Reimann, K., Jankuhn, S., Kirilina, E. P., Stieler, J., Sonntag, M., Meijer, J., Weiskopf, N., Reinert, T., Arendt, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01145-2 · Cited by 70
Mapping Brain Metals to Evaluate Therapies for Neurodegenerative Disease
Popescu, B. F. G., & Nichol, H. K. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00149.x · Cited by 68
Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys
Cass, W. A., Grondin, R., Andersen, A. H., Zhang, Z., Hardy, P. A., Hussey-Andersen, L. K., Rayens, W. S., Gerhardt, G. A., & Gash, D. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.010 · Cited by 67
Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein
Jinsmaa, Y., Sullivan, P., Gross, D., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.03.016 · Cited by 68
Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: Similarity with paraquat neurotoxicity
Kumar, A., Singh, B. K., Ahmad, I., Shukla, S., Patel, D. K., Srivastava, G., Kumar, V., Pandey, H. P., & Singh, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.12.028 · Cited by 70
Cysteine Oxidation within N-terminal Mutant Huntingtin Promotes Oligomerization and Delays Clearance of Soluble Protein
Fox, J. H., Connor, T., Stiles, M. A., Kama, J. A., Lü, Z., Dorsey, K., Liebermann, G., Sapp, E., Cherny, R. A., Banks, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199448 · Cited by 72
Oligomeric alpha‐synuclein and its role in neuronal death
Brown, D. R. (2010) · IUBMB Life · doi:10.1002/iub.316 · Cited by 69
A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases
Singh, Y. P., Pandey, A., Vishwakarma, S., & Modi, G. P. (2018) · Molecular Diversity · doi:10.1007/s11030-018-9878-4 · Cited by 69
Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease
Chege, P. M., & McColl, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00089 · Cited by 68
Dexras1, a Small GTPase, Is Required for Glutamate-NMDA Neurotoxicity
Chen, Y., Khan, R. S., Cwanger, A., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1497-12.2013 · Cited by 67
Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross‐sectional study of iron‐related magnetic resonance imaging susceptibility
Martín‐Bastida, A., Lao–Kaim, N. P., Loane, C., Politis, M., Roussakis, A., Valle‐Guzman, N., Kefalopoulou, Z. M., Paul, G., Widner, H., Xing, Y., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.13208 · Cited by 67
Brain iron in the ferrocene-loaded rat: Its chelation and influence on dopamine metabolism
Ward, R. J., Dexter, D. T., Florence, A., Aouad, F., Hider, R. C., Jenner, P. G., & Crichton, R. R. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)00521-m · Cited by 67
Self-citation
Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity
Mohanakumar, K. P., Hanbauer, I., & Chiueh, C. C. (1998) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(98)00032-5 · Cited by 69
The Role of Conformational Dynamics and Allostery in the Disease Development of Human Ferritin
Kumar, A., Glembo, T. J., & Ozkan, S. B. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.06.060 · Cited by 61
Wilson disease
Poujois, A., Mikol, J., & Woimant, F. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63625-6.00008-2 · Cited by 66
Evidence of Functional Zinc Deficiency in Parkinson's Disease
Forsleff, L., Schauss, A. G., Bier, I. D., & Stuart, S. M. (1999) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.1999.5.57 · Cited by 66
Effect of zinc and paraquat co-exposure on neurodegeneration: Modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats
Kumar, A., Ahmad, I., Shukla, S., Singh, B. K., Patel, D. K., Pandey, H. P., & Singh, C. (2010) · Free Radical Research · doi:10.3109/10715762.2010.492832 · Cited by 65
Serological Profiles of Urate, Paraoxonase-1, Ferritin and Lipid in Parkinson’s Disease: Changes Linked to Disease Progression
Ikeda, K., Nakamura, Y., Kiyozuka, T., Aoyagi, J., Hirayama, T., Nagata, R., Ito, H., Iwamoto, K., Murata, K., Yoshii, Y., et al. (2011) · Neurodegenerative Diseases · doi:10.1159/000323265 · Cited by 66
Parkinson's disease–related increase of ‐weighted hypointensity in substantia nigra pars compacta
Langley, J. A., Huddleston, D. E., Sedlacik, J., Boelmans, K., & Hu, X. P. (2016) · Movement Disorders · doi:10.1002/mds.26883 · Cited by 64
T2*-weighted MRI in diagnosis of multiple system atrophy
von Lewinski, F., Werner, C., Jörn, T., Mohr, A., Sixel‐Döring, F., & Trenkwalder, C. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0496-1 · Cited by 62
Neonatal iron exposure induces oxidative stress in adult Wistar rat
Dal‐Pizzol, F., Klamt, F., da Frota, M. L. C., Andrades, M. É., Caregnato, F. F., Vianna, M. R. M. R., Schröder, N., Quevedo, J., Izquierdo, I., Archer, T., et al. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00218-8 · Cited by 64
Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease
Baksi, S., Tripathi, A. K., & Singh, N. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.025 · Cited by 64
Dolichol is the major lipid component of human substantia nigra neuromelanin
Fedorow, H., Pickford, R., Hook, J. M., Double, K. L., Halliday, G. M., Gerlach, M., Riederer, P. F., & Garner, B. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02975.x · Cited by 64
Sources and triggers of oxidative damage in neurodegeneration
Angelova, P. R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.003 · Cited by 67
Iron Deposition in Parkinson’s Disease: A Mini-Review
Zeng, W., Cai, J., Zhang, L., & Peng, Q. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01459-4 · Cited by 64
Elevated brain iron is independent from atrophy in Huntington's Disease
Dumas, E. M., Versluis, M. J., van den Bogaard, S. J. A., van Osch, M. J. P., Hart, E. P., van Roon‐Mom, W., van Buchem, M. A., WEBB, A. G., van der Grond, J., & Roos, R. A. C. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.056 · Cited by 62
The R6 lines of transgenic mice: A model for screening new therapies for Huntington's disease
Gil‐Mohapel, J., & Rego, A. C. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.001 · Cited by 67
Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson’s disease
Bharucha, K. J., Friedman, J. H., Vincent, A. S., & Ross, E. D. (2008) · Journal of Neurology · doi:10.1007/s00415-009-0063-7 · Cited by 62
Pantothenate Kinase-Associated Neurodegeneration
Hartig, M., Prokisch, H., Meitinger, T., & Klopstock, T. (2012) · Current Drug Targets · doi:10.2174/138945012802002384 · Cited by 63
Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease
Liddell, J. R., & White, A. R. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.016 · Cited by 64
Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits
Zhang, J., Stanton, D. M., Nguyen, X. V., Liu, M., Zhang, Z., Gash, D. M., & Bing, G. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.049 · Cited by 64
Supported Treadmill Training for Gait and Balance in a Patient With Progressive Supranuclear Palsy
Suteerawattananon, M., MacNeill, B., & Protas, E. J. (2002) · Physical Therapy · doi:10.1093/ptj/82.5.485 · Cited by 63
A brief history of brain iron accumulation in Parkinson disease and related disorders
Foley, P. B., Hare, D. J., & Double, K. L. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02505-5 · Cited by 61
Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases
Ban, X.-X., Wan, H., Wan, X.-X., Tan, Y.-T., Hu, X., Ban, H.-X., Chen, X., Huang, K. L., Zhāng, Q., & Xiong, K. (2024) · Current Medical Science · doi:10.1007/s11596-024-2832-z · Cited by 68
Ferroptosis in Parkinson's disease —— The iron-related degenerative disease
Yao, Z., Jiao, Q., Du, X., Jia, F., Chen, X., Yan, C., & Jiang, H. F. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102477 · Cited by 65
Ageing neuroinflammation and neurodegeneration
Ward, R. J. (2015) · Frontiers in Bioscience-Scholar · doi:10.2741/s433 · Cited by 64
Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification
Bjørklund, G., Hofer, T., Nurchi, V. M., & Aaseth, J. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110717 · Cited by 62
Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?
Lee, D. W., & Andersen, J. K. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06470.x · Cited by 63
Metal binding to alpha-synuclein peptides and its contribution to toxicity
Brown, D. R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.103 · Cited by 61
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol
da Silva, V. K., de Freitas, B. S., Dornelles, V. C., Kist, L. W., Bogo, M. R., Silva, M. C., STRECK, E. L., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., et al. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.014 · Cited by 65
Phosphorylation-dependent metal binding by α-synuclein peptide fragments
Liu, L. L., & Franz, K. J. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0181-y · Cited by 61
Recent advances in understanding haemochromatosis: a transition state
Robson, K., Merryweather-Clarke, A. T., Cadet, E., Viprakasit, V., Zaahl, M. G., Pointon, J. J., Weatherall, D. J., & Rochette, J. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.020644 · Cited by 62
Altered Manganese Homeostasis and Manganese Toxicity in a Huntington's Disease Striatal Cell Model Are Not Explained by Defects in the Iron Transport System
Williams, B. B., Kwakye, G. F., Węgrzynowicz, M., Li, D. D., Aschner, M., Erikson, K. M., & Bowman, A. B. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq174 · Cited by 60
PPARα controls the intracellular coenzyme A concentration via regulation of PANK1α gene expression
Ramaswamy, G., Karim, M. A., Murti, K. G., & Jackowski, S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300279-jlr200 · Cited by 60
T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
Atasoy, H. T., Nuyan, O., Tunç, T., et al. (2004) · PubMed · Cited by 60
Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study
He, Y., Thong, P. S. P., Lee, T., Leong, S. K., Shi, C., Wong, P. T. ‐., Yuan, S. Y., & Watt, F. (1996) · Brain Research · doi:10.1016/0006-8993(96)00313-7 · Cited by 61
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
Bourdenx, M., Nioche, A., Doveró, S., Arotçarena, M.-L., Camus, S. M. J., Porras, G., Thiolat, M.-L., Rougier, N. P., Prigent, A., Aubert, P., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz9165 · Cited by 64
Evaluation of new iron chelators and their therapeutic potential
Aouad, F., Florence, A., Zhang, Y., Collins, F., Henry, C., Ward, R. J., & Crichton, R. R. (2002) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(02)01040-x · Cited by 58
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)
McNaught, K. S. P., Thull, U., Carrupt, P., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02086-1 · Cited by 58
Self-citation
Imaging Brain Iron and Diffusion Patterns
Rossi, M. E., Ruottinen, H., Saunamäki, T., et al. (2013) · Academic Radiology · doi:10.1016/j.acra.2013.09.018 · Cited by 57
Structural basis behind the interaction of Zn2+ with the protein α-synuclein and the Aβ peptide: A comparative analysis
Valiente‐Gabioud, A. A., Monserrat, V. T., Molina-Rubino, L., Binolfi, A., Griesinger, C., & Fernández, C. O. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.06.011 · Cited by 57
Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach
Toni, M., Massimino, M. L., Mario, A. D., Angiulli, E., & Spisni, E. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00003 · Cited by 56
Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
Ferini‐Strambi, L., Carli, G., Casoni, F. M., & Galbiati, A. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00551 · Cited by 57
Long Term Exposure to Manganese in Rural Well Water Has No Neurological Effects
Vieregge, P., Heinzow, B., Korf, G., et al. (1995) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100039482 · Cited by 57
Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment
Fillebeen, C., Mitchell, V. A., Dexter, D. T., Benaı̈ssa, M., Beauvillain, J., Spik, G., & Pierce, A. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00221-1 · Cited by 56
Self-citation
Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
Gadhe, L. G., Sakunthala, A., Mukherjee, S., Gahlot, N., Bera, R., Sawner, A. S., Kadu, P., & Maji, S. K. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106736 · Cited by 56
α-Synuclein as a ferrireductase
Brown, D. R. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130130 · Cited by 57
Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease
Hands, S. L., Mason, R. P., Sajjad, M. U., Giorgini, F., & Wyttenbach, A. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380552 · Cited by 55
Magnetic resonance fingerprinting with quadratic RF phase for measurement of T2* simultaneously with δf, T1, and T2
Wang, C. Y., Coppo, S., Mehta, B. B., Seiberlich, N., Yu, X., & Griswold, M. A. (2018) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27543 · Cited by 56
Lipid peroxidation associated protein damage in rat brain crude synaptosomal fraction mediated by iron and ascorbate
Chakraborty, H., Ray, S. N., & Chakrabarti, S. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00117-0 · Cited by 56
Iron Deficiency in Parkinsonism: Region-Specific Iron Dysregulation in Parkinson's Disease and Multiple System Atrophy
Visanji, N. P., Collingwood, J. F., Finnegan, M. E., Tandon, A., House, E. R., & Hazrati, L. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130197 · Cited by 57
Ferritin iron uptake and release in the presence of metals and metalloproteins: Chemical implications in the brain
Carmona, F., Palacios, Ò., Gálvez, N., Cuesta, R., Atrian, S., Capdevila, M., & Dominguez-Vera, J. M. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.03.034 · Cited by 56
Development of methods for the quantification of essential and toxic elements in human biomonitoring.
Bocca, B., Forte, G., Petrucci, F., Senofonte, O., Violante, N., & Alimonti, A. (2005) · PubMed · Cited by 54
A moderate metal-binding hydrazone meets the criteria for a bioinorganic approach towards Parkinson's disease: Therapeutic potential, blood-brain barrier crossing evaluation and preliminary toxicological studies
Cukierman, D. S., Pinheiro, A. B., Filho, S. L. P. C., da Silva, A. S. P., Miotto, M., Falco, A. D., Ribeiro, T. D. P., Maisonnette, S. S., da Cunha, A. L. M. C., Hauser‐Davis, R. A., et al. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.02.020 · Cited by 57
Iron-related nigral degeneration influences functional topology mediated by striatal dysfunction in Parkinson's disease
Guan, X., Zhang, Y., Wei, H., Guo, T., Zeng, Q., Zhou, C., Wang, J., Gao, T., Xuan, M., Gu, Q., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.11.013 · Cited by 56
Reversion of age-related recognition memory impairment by iron chelation in rats
de Lima, M. N. M., Dias, C. P., Torres, J. P., Dornelles, A. D. S., Garcia, V. A., Scalco, F. S., Guimarães, M. R., Petry, R. C., Bromberg, E., Constantino, L. D. S., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.006 · Cited by 55
Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
Singh, C., Ahmad, I., & Kumar, A. (2007) · PubMed · Cited by 54
Limbic system pathologies associated with deficiencies and excesses of the trace elements iron, zinc, copper, and selenium
Torres-Vega, A., Pliego‐Rivero, B., Otero, G., Gómez‐Oliván, L. M., & Vieyra-Reyes, P. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00521.x · Cited by 55
Serum levels of zinc and copper in patients with Parkinson's disease
Jiménez‐Jiménez, F. J., Fernández–Calle, P., Martı́nez, M., Herrero, E., Molina, J. A., Vázquez, A., & Codoceo, R. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90127-7 · Cited by 54
Pharmacology of Lazaroids and Brain Energy Metabolism: A Review
Villa, R. F., & Gorini, A. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01314-0 · Cited by 54
Paraquat induced activation of transcription factor AP-1 and apoptosis in PC12 cells
Li, X., & Sun, A. Y. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050137 · Cited by 54

Authors: DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D.
Affiliations: King's College London (GB)
Inserm (FR)
Parkinson's UK (GB)
Corresponding author: JENNER, P.
ORCID: DEXTER, D. T.
DANIEL, S. E
LEES, A. J.
JENNER, P.
Venue: Brain
Publisher: Oxford University Press (OUP)
Published: 1991
Volume: 114
Issue: 4
Pages: 1953-1975
ISSN: 0006-8950 (ISSN-L)
1460-2156
DOI: 10.1093/brain/114.4.1953
OpenAlex: W2123913108
Cited by: 1,043
References: 0
Citations by year: 2026: 18 · 2025: 29 · 2024: 47 · 2023: 28 · 2022: 37 · 2021: 43 · 2020: 36 · 2019: 38 · 2018: 30 · 2017: 45 · 2016: 56 · 2015: 45 · 2014: 41 · 2013: 44 · 2012: 32
FWCI: 12.57
Type: journal article
Language: en
Open access: closed
Locations: Brain (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Royal Society
Topics: Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords: Parkinson's disease, progressive supranuclear palsy, multiple system atrophy, Huntington's disease, basal ganglia, iron, ferritin, copper, zinc, manganese, substantia nigra, striatum, globus pallidus, neurodegeneration, trace metals, iron overload
MeSH terms: Aging, Atrophy, Basal Ganglia Diseases, Brain, Brain Diseases, Ferritins, Humans, Huntington Disease, Iron, Metals, Parkinson Disease, Radioimmunoassay, Reference Values, Supranuclear Palsy, Progressive, Trace Elements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE METALS IN PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks